Cited by 2,029RNA Research and SplicingAcute Myeloid Leukemia ResearchGenomics and Rare Diseases

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Frequent pathway mutations of splicing machinery in myelodysplasia

Yoshida, Kenichi, Sanada, Masashi, Shiraishi, Yuichi, Nowak, Daniel, Nagata, Yasunobu, Yamamoto, Ryo, Sato, Yusuke, Sato-Otsubo, Aiko, Kon, Ayana, Nagasaki, Masao, Chalkidis, George, Suzuki, Yutaka, Shiosaka, Masashi, Kawahata, Ryoichiro, Yamaguchi, Tomoyuki, Otsu, Makoto, Obara, Naoshi, Sakata-Yanagimoto, Mamiko, Ishiyama, Ken, Mori, Hiraku, Nolte, Florian, Hofmann, Wolf-Karsten, Miyawaki, Shuichi, Sugano, Sumio, Haferlach, Claudia, Koeffler, H. Phillip, Shih, Lee-Yung, Haferlach, Torsten, Chiba, Shigeru, Nakauchi, Hiromitsu, Miyano, Satoru, Ogawa, Seishi·2011·Nature

DOI 10.1038/nature10496

Open this paper in CoChat — free account

Abstract

Myelodysplastic syndromes and related disorders (myelodysplasia) are a heterogeneous group of myeloid neoplasms showing deregulated blood cell production with evidence of myeloid dysplasia and a predisposition to acute myeloid leukaemia, whose pathogenesis is only incompletely understood. Here we report whole-exome sequencing of 29 myelodysplasia specimens, which unexpectedly revealed novel pathway mutations involving multiple components of the RNA splicing machinery, including U2AF35, ZRSR2, SRSF2 and SF3B1. In a large series analysis, these splicing pathway mutations were frequent (∼45 to ∼85%) in, and highly specific to, myeloid neoplasms showing features of myelodysplasia. Conspicuously, most of the mutations, which occurred in a mutually exclusive manner, affected genes involved in the 3'-splice site recognition during pre-mRNA processing, inducing abnormal RNA splicing and compromised haematopoiesis. Our results provide the first evidence indicating that genetic alterations of the major splicing components could be involved in human pathogenesis, also implicating a novel therapeutic possibility for myelodysplasia.

Integrity signals

Registry

Crossref · 10.1038/nature10496

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066
Next-generation DNA sequencing
Shendure, J., & Ji, H. (2008) · Nature Biotechnology · doi:10.1038/nbt1486 · Cited by 4,509
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Morin, R. D., Johnson, N. A., Severson, T., Mungall, A. J. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,719
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramís, G., Jares, P., Beà, S., González, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,529
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C. L., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,457
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D. J., Dunford-Shore, B. H., McGrath, S. D., Hickenbotham, M. T., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,434

Show all 37 references

Sorted by citations

Items 101–200 of 1,002

MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Kwok, B., Hall, J., Witte, J. S., Xu, Y., Reddy, P., Lin, K., Flamholz, R., Dabbas, B., Yung, A., Al-Hafidh, J., et al. (2015) · Blood · doi:10.1182/blood-2015-08-667063 · Cited by 322
Lessons from non-canonical splicing
Sibley, C. R., Blázquez, L., & Ule, J. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.46 · Cited by 327
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Sciarrillo, R., Wojtuszkiewicz, A., Assaraf, Y. G., Jansen, G., Kaspers, G. J. L., Giovannetti, E., & Cloos, J. J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100728 · Cited by 317
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Meggendorfer, M., Roller, A., Haferlach, T., Eder, C., Dicker, F., Grossmann, V., Kohlmann, A., Alpermann, T., Yoshida, K., Ogawa, S., et al. (2012) · Blood · doi:10.1182/blood-2012-01-404863 · Cited by 309
Self-citation
Misregulation of Pre-mRNA Alternative Splicing in Cancer
Zhang, J., & Manley, J. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0253 · Cited by 316
Splicing regulation by long noncoding RNAs
Romero-Barrios, N., Legascue, M. F., Benhamed, M., Ariel, F., & Crespi, M. D. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky095 · Cited by 319
Alternative splicing in cancer: implications for biology and therapy
Chen, J., & Weiss, W. A. (2014) · Oncogene · doi:10.1038/onc.2013.570 · Cited by 309
Aberrant RNA Splicing in Cancer
Escobar‐Hoyos, L. F., Knorr, K. L. B., & Abdel-Wahab, O. I. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050407 · Cited by 303
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Malcovati, L., Stevenson, K. E., Papaemmanuil, E., Neuberg, D. S., Bejar, R. L., Boultwood, J., Bowen, D., Campbell, P. J., Ebert, B. L., Fenaux, P., et al. (2020) · Blood · doi:10.1182/blood.2020004850 · Cited by 304
Self-citation
Splicing-factor alterations in cancers
Anczuków, O., & Krainer, A. R. (2016) · RNA · doi:10.1261/rna.057919.116 · Cited by 304
Transcriptional diversity during lineage commitment of human blood progenitors
Chen, L., Kostadima, M. A., Martens, J. H. A., Canu, G., Garcia, S. P., Turro, E., Downes, K., Macaulay, I. C., Bielczyk-Maczyńska, E., Coe, S., et al. (2014) · Science · doi:10.1126/science.1251033 · Cited by 311
The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations
Chen, L., Chen, J., Huang, Y.-J., Gu, Y., Qiu, J., Qian, H., Shao, C., Zhang, X., Hu, J., Li, H., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.029 · Cited by 304
Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
Das, S., & Krainer, A. R. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0131 · Cited by 292
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
Traina, F., Visconte, V., Elson, P. J., Tabarroki, A., Jankowska, A., Hasrouni, E., Sugimoto, Y., Szpurka, H., Makishima, H., O'Keefe, C., et al. (2013) · Leukemia · doi:10.1038/leu.2013.269 · Cited by 296
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Shirai, C. L., Ley, J. N., White, B. S., Kim, S., Tibbitts, J., Shao, J., Ndonwi, M., Wadugu, B., Duncavage, E. J., Okeyo-Owuor, T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.008 · Cited by 287
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Poon, S. L., Pang, S., McPherson, J. R., Yu, W., Huang, K. K., Guan, P., Weng, W., Siew, E. Y., Liu, Y., Heng, H. L., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006086 · Cited by 289
U2AF1 mutations alter splice site recognition in hematological malignanciesPreprint
Ilagan, J. O., Ramakrishnan, A., Hayes, B. J., Murphy, M. E., Zebari, A. S., Bradley, P. H., & Bradley, R. K. (2014) · Genome Research · doi:10.1101/gr.181016.114 · Cited by 293
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
Walter, M. J., Shen, D., Shao, J., Ding, L., White, B. S., Kandoth, C., Miller, C. A., Niu, B., McLellan, M. D., Dees, N. D., et al. (2013) · Leukemia · doi:10.1038/leu.2013.58 · Cited by 284
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
Patnaik, M. M., Itzykson, R., Lasho, T. L., Kosmider, O., Finke, C. M., Hanson, C. A., Knudson, R. A., Ketterling, R. P., Tefferi, A., & Solary, É. (2014) · Leukemia · doi:10.1038/leu.2014.125 · Cited by 286
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
Fong, J. Y., Pignata, L., Goy, P.-A. V., Kawabata, K. C., Lee, S. C.-W., Koh, C. M., Musiani, D., Massignani, E., Kotini, A. G., Penson, A., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.07.003 · Cited by 294
Circular RNA in cancer
Conn, V. M., Chinnaiyan, A. M., & Conn, S. J. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00721-7 · Cited by 300
Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
Sebestyén, E., Singh, B., Miñana, B., Pagès, A., Mateo, F., Pujana, M. A., Valcárcel, J., & Eyras, E. (2016) · Genome Research · doi:10.1101/gr.199935.115 · Cited by 276
Clonal architecture of chronic myelomonocytic leukemias
Itzykson, R., Kosmider, O., Renneville, A., Morabito, M., Preudhomme, C., Berthon, C., Adès, L., Fenaux, P., Platzbecker, U., Gagey, O., et al. (2013) · Blood · doi:10.1182/blood-2012-06-440347 · Cited by 291
The genomic landscape of core-binding factor acute myeloid leukemias
Faber, Z. J., Chen, X. '., Gedman, A. L., Boggs, K., Cheng, J., Ma, J., Radtke, I., Chao, J.-R., Walsh, M. P., Song, G., et al. (2016) · Nature Genetics · doi:10.1038/ng.3709 · Cited by 276
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects
Rogalska, M. E., Vivori, C., & Valcárcel, J. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00556-8 · Cited by 284
Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients
Damm, F., Mylonas, E., Cosson, A., Yoshida, K., Della-Valle, V., Mouly, E., Diop, M. K., Scourzic, L., Shiraishi, Y., Chiba, K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0104 · Cited by 280
Self-citation
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome
Kulasekararaj, A. G., Jiang, J., Smith, A., Mohamedali, A. M., Mian, S. A., Gandhi, S., Gäken, J. A., Czepulkowski, B. H., Marsh, J. C. W., & Mufti, G. J. (2014) · Blood · doi:10.1182/blood-2014-05-574889 · Cited by 268
Connections between TET proteins and aberrant DNA modification in cancer
Huang, Y., & Rao, A. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.07.005 · Cited by 274
Comprehensive mutational profiling in advanced systemic mastocytosis
Schwaab, J., Schnittger, S., Sotlar, K., Walz, C., Fabarius, A. C., Pfirrmann, M., Kohlmann, A., Großmann, V., Meggendorfer, M., Horny, H., et al. (2013) · Blood · doi:10.1182/blood-2013-04-496448 · Cited by 268
Self-citation
Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis
Kakiuchi, N., Yoshida, K., Uchino, M., Kihara, T., Akaki, K., Inoue, Y., Kawada, K., Nagayama, S., Yokoyama, A., Yamamoto, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1856-1 · Cited by 262
Self-citation
Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS
Agrawal, N., Jiao, Y., Sausen, M., Leary, R. J., Bettegowda, C., Roberts, N. J., Bhan, S., Ho, A. S., Khan, Z. H., Bishop, J. A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2703 · Cited by 258
Somatic SETBP1 mutations in myeloid malignancies
Makishima, H., Yoshida, K., Nguyen, N., Przychodzen, B. P., Sanada, M., Okuno, Y., Ng, K. P., Gudmundsson, K. O., Vishwakarma, B. A., Jerez, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2696 · Cited by 262
Self-citation
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation
Porta, M. G. D., Gallì, A., Bacigalupo, A. P., Zibellini, S., Bernardi, M., Rizzo, E., Allione, B., Lint, M. T. V., Pioltelli, P. E., Marenco, P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.3616 · Cited by 261
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
Malcovati, L., Papaemmanuil, E., Ambaglio, I., Elena, C., Gallì, A., Porta, M. G. D., Travaglino, E., Pietra, D., Pascutto, C., Ubezio, M., et al. (2014) · Blood · doi:10.1182/blood-2014-03-560227 · Cited by 259
TP 53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis
Kulasekararaj, A. G., Smith, A. E., Mian, S. A., Mohamedali, A. M., Krishnamurthy, P., Lea, N. C., Gäken, J., Pennaneach, C., Ireland, R., Czepulkowski, B., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12203 · Cited by 250
Alternative mRNA splicing in cancer immunotherapy
Frankiw, L., Baltimore, D., & Li, G. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0195-7 · Cited by 253
Genetic alterations of the cohesin complex genes in myeloid malignancies
Thota, S., Viny, A. D., Makishima, H., Spitzer, B. G., Radivoyevitch, T., Przychodzen, B. P., Sekeres, M. A., Levine, R. L., & Maciejewski, J. P. (2014) · Blood · doi:10.1182/blood-2014-04-567057 · Cited by 247
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies
Smith, M. A., Choudhary, G. S., Pellagatti, A., Choi, K., Bolanos, L. C., Bhagat, T. D., Gordon-Mitchell, S., Ahrens, D. V., Pradhan, K., Steeples, V., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0314-5 · Cited by 253
Genome-wide discovery of human splicing branchpointsPreprint
Mercer, T. R., Clark, M. B., Andersen, S. B., Brunck, M. E. G., Haerty, W., Crawford, J., Taft, R. J., Nielsen, L. K., Dinger, M. E., & Mattick, J. S. (2015) · Genome Research · doi:10.1101/gr.182899.114 · Cited by 244
Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
Kihara, R., Nagata, Y., Kiyoi, H., Kato, T., Yamamoto, E., Suzuki, K., Chen, F., Asou, N., Ohtake, S., Miyawaki, S., et al. (2014) · Leukemia · doi:10.1038/leu.2014.55 · Cited by 253
Self-citation
RNA Splicing and Cancer
Wang, E., & Aifantis, I. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.011 · Cited by 246
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
Pellagatti, A., Armstrong, R. N., Steeples, V., Sharma, E., Repapi, E., Singh, S., Sanchi, A., Radujkovic, A., Horn, P., Dolatshad, H., et al. (2018) · Blood · doi:10.1182/blood-2018-04-843771 · Cited by 248
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Madan, V., Kanojia, D., Li, J., Okamoto, R., Sato‐Otsubo, A., Kohlmann, A., Sanada, M., Großmann, V., Sundaresan, J., Shiraishi, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7042 · Cited by 249
Self-citation
Splicing Kinetics and Coordination Revealed by Direct Nascent RNA Sequencing through Nanopores
Drexler, H. L., Choquet, K., & Churchman, L. S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.11.017 · Cited by 237
Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
Damm, F., Kosmider, O., Gelsi‐Boyer, V., Renneville, A., Carbuccia, N., Hidalgo-Curtis, C., Della-Valle, V., Couronné, L., Scourzic, L., Chesnais, V., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400994 · Cited by 244
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes
Sallman, D. A., Komrokji, R., Vaupel, C., Cluzeau, T., Geyer, S. M., McGraw, K. L., Al Ali, N. H., Lancet, J., McGinniss, M. J., Nahas, S., et al. (2016) · Leukemia · doi:10.1038/leu.2015.304 · Cited by 231
Control of mammalian gene expression by selective mRNA export
Wickramasinghe, V. O., & Laskey, R. A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4010 · Cited by 238
Spliceosomal disruption of the non-canonical BAF complex in cancer
Inoue, D., Chew, G.-L., Liu, B., Michel, B. C., Pangallo, J., D’Avino, A. R., Hitchman, T. D., North, K., Lee, S. C.-W., Bitner, L. E., et al. (2019) · Nature · doi:10.1038/s41586-019-1646-9 · Cited by 233
Kinetic competition during the transcription cycle results in stochastic RNA processing
Coulon, A., Ferguson, M., de Turris, V., Palangat, M., Chow, C. C., & Larson, D. R. (2014) · eLife · doi:10.7554/elife.03939 · Cited by 229
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes
Hamard, P.-J., Santiago, G. E., Liu, F., Karl, D. L., Martínez, C., Man, N., Mookhtiar, A. K., Duffort, S., Greenblatt, S. M., Verdún, R. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.002 · Cited by 232
Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation
Frick, M., Chan, W., Arends, C. M., Hablesreiter, R., Halik, A., Heuser, M., Michonneau, D., Blau, O., Hoyer, K., Christen, F., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2184 · Cited by 223
Self-citation
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
Sakaguchi, H., Okuno, Y., Muramatsu, H., Yoshida, K., Shiraishi, Y., Takahashi, M., Kon, A., Sanada, M., Chiba, K., Tanaka, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2698 · Cited by 227
Self-citation
Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site
Mazhab-Jafari, M. T., Marshall, C. B., Smith, M. J., Gasmi-Seabrook, G. M. C., Stathopulos, P. B., Inagaki, F., Kay, L. E., Neel, B. G., & Ikura, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419895112 · Cited by 220
Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer
Kulis, M., Queirós, A. C., Beekman, R., & Martín-Subero, J. I. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.08.001 · Cited by 230
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
Patnaik, M. M., Padron, E., Laborde, R. R., Lasho, T. L., Finke, C. M., Hanson, C. A., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Al‐Kali, A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.88 · Cited by 222
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
Bywater, M. J., Pearson, R. B., McArthur, G. A., & Hannan, R. D. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3496 · Cited by 224
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Bersanelli, M., Travaglino, E., Meggendorfer, M., Matteuzzi, T., Sala, C., Mosca, E., Chiereghin, C., Nanni, N. D., Gnocchi, M., Zampini, M., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01659 · Cited by 228
Self-citation
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations
Lee, S. C.-W., North, K., Kim, E., Jang, E., Obeng, E., Lu, S. X., Liu, B., Inoue, D., Yoshimi, A., Ki, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.003 · Cited by 219
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome
Zhang, S.-J., Rampal, R. K., Manshouri, T., Patel, J. L., Mensah, N. Y., Kayserian, A., Hricik, T., Heguy, A., Hedvat, C. V., Gönen, M., et al. (2012) · Blood · doi:10.1182/blood-2011-11-390252 · Cited by 229
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders
Damm, F., Chesnais, V., Nagata, Y., Yoshida, K., Scourzic, L., Okuno, Y., Itzykson, R., Sanada, M., Shiraishi, Y., Gelsi‐Boyer, V., et al. (2013) · Blood · doi:10.1182/blood-2012-11-469619 · Cited by 226
Self-citation
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Merlevede, J., Droin, N. M., Qin, T., Meldi, K. M., Yoshida, K., Morabito, M., Chautard, É., Auboeuf, D., Fenaux, P., Braun, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms10767 · Cited by 225
Self-citation
Mouse totipotent stem cells captured and maintained through spliceosomal repression
Shen, H., Yang, M., Li, S., Zhang, J., Peng, B., Wang, C., Chang, Z., Ong, J., & Du, P. (2021) · Cell · doi:10.1016/j.cell.2021.04.020 · Cited by 221
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
Ferreira, P. G., Jares, P., Rico, D., Gómez-López, G., Martínez-Trillos, A., Villamor, N., Ecker, S., González-Pérez, A., Knowles, D. G., Monlong, J., et al. (2014) · Genome Research · doi:10.1101/gr.152132.112 · Cited by 214
YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner
Feng, M., Xie, X., Han, G., Zhang, T., Li, Y., Li, Y., Yin, R., Wang, Q., Zhang, T., Wang, P., et al. (2021) · Blood · doi:10.1182/blood.2020009676 · Cited by 213
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities
Zhang, J., Lieu, Y. K., Ali, A. M., Penson, A., Reggio, K. S., Rabadán, R., Raza, A., Mukherjee, S., & Manley, J. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514105112 · Cited by 223
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
Oscier, D. G., Rose-Zerilli, M. J. J., Winkelmann, N., de Castro, D. G., Gomez, B., Forster, J., Parker, H., Parker, A. E., Gardiner, A. C., Collins, A. R., et al. (2012) · Blood · doi:10.1182/blood-2012-05-429282 · Cited by 216
Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers
DeBoever, C., Ghia, E. M., Shepard, P. J., Rassenti, L. Z., Barrett, C. L., Jepsen, K., Jamieson, C. H. M., Carson, D. A., Kipps, T. J., & Frazer, K. A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004105 · Cited by 220
Defective control of pre–messenger RNA splicing in human disease
Chabot, B., & Shkreta, L. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201510032 · Cited by 220
The genomic landscape of pediatric myelodysplastic syndromes
Schwartz, J. R., Ma, J., Westover, T., Walsh, M. P., Wang, S., Bryant, V. L., Song, G., Wu, G., Easton, J. B., Kesserwan, C. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01590-5 · Cited by 213
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
Garg, M., Nagata, Y., Kanojia, D., Mayakonda, A., Yoshida, K., Keloth, S. H., Zang, Z. J., Okuno, Y., Shiraishi, Y., Chiba, K., et al. (2015) · Blood · doi:10.1182/blood-2015-05-646240 · Cited by 212
Self-citation
The functional consequences of intron retention: Alternative splicing coupled to NMD as a regulator of gene expression
Ge, Y. C., & Porse, B. T. (2013) · BioEssays · doi:10.1002/bies.201300156 · Cited by 219
ACTN1 Mutations Cause Congenital Macrothrombocytopenia
Kunishima, S., Okuno, Y., Yoshida, K., Shiraishi, Y., Sanada, M., Muramatsu, H., Chiba, K., Tanaka, H., Miyazaki, K., Sakai, M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.015 · Cited by 205
Self-citation
A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition
Goff, D. J., Recart, A. C., Sadarangani, A., Chun, H.-J. E., Barrett, C. L., Krajewska, M., Leu, H. S., Low-Marchelli, J. M., Ma, W., Shih, A. Y., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2012.12.011 · Cited by 206
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
Patnaik, M. M., Lasho, T. L., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Garcia‐Manero, G., Steensma, D. P., Pardanani, A. D., Hanson, C. A., & Tefferi, A. (2011) · Blood · doi:10.1182/blood-2011-09-377994 · Cited by 205
Splice site m6A methylation prevents binding of U2AF35 to inhibit RNA splicing
Mendel, M., Delaney, K., Pandey, R. R., Chen, K., Wenda, J. M., Vågbø, C. B., Steiner, F. A., Homolka, D., & Pillai, R. S. (2021) · Cell · doi:10.1016/j.cell.2021.03.062 · Cited by 200
An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data
Shiraishi, Y., Sato, Y., Chiba, K., Okuno, Y., Nagata, Y., Yoshida, K., Shiba, N., Hayashi, Y., Kume, H., Homma, Y., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt126 · Cited by 202
Self-citation
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
Steensma, D. P., Wermke, M., Klimek, V. M., Greenberg, P. L., Font, P., Komrokji, R. S., Yang, J., Brunner, A. M., Carraway, H. E., Adès, L., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01328-9 · Cited by 206
Tau-mediated disruption of the spliceosome triggers cryptic rna splicing and neurodegeneration in Alzheimer's Disease
Hsieh, Y.-C., Guo, C., Yalamanchili, H. K., Abreha, M., Al-Ouran, R., Li, Y., Dammer, E. B., Lah, J. J., Levey, A. I., Bennett, D. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.104 · Cited by 196
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
Thol, F. R., Bollin, R., Gehlhaar, M. A., Walter, C., Dugas, M., Suchanek, K. J., Kirchner, A., Huang, L., Chaturvedi, A., Wichmann, M., et al. (2013) · Blood · doi:10.1182/blood-2013-07-518746 · Cited by 202
Punctuated evolution of canonical genomic aberrations in uveal melanoma
Field, M. G., Durante, M. A., Anbunathan, H., CAI, L. Z., Decatur, C. L., Bowcock, A. M., Kurtenbach, S., & Harbour, J. W. (2018) · Nature Communications · doi:10.1038/s41467-017-02428-w · Cited by 198
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Arends, C. M., Galan-Sousa, J., Hoyer, K., Chan, W., Jäger, M., Yoshida, K., Seemann, R., Noerenberg, D., Waldhueter, N., Fleischer-Notter, H., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0047-7 · Cited by 194
Self-citation
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
Dolatshad, H., Pellagatti, A., Fernández‐Mercado, M., Yip, B. H., Malcovati, L., Attwood, M., Przychodzen, B. P., Sahgal, N., Kanapin, A. A., Lockstone, H. E., et al. (2014) · Leukemia · doi:10.1038/leu.2014.331 · Cited by 202
Self-citation
Myelodysplastic syndromes: Contemporary review and how we treat
Gangat, N., Patnaik, M. M., & Tefferi, A. (2015) · American Journal of Hematology · doi:10.1002/ajh.24253 · Cited by 200
Impact of Alternative Splicing on the Human Proteome
Liu, Y., Gonzàlez-Porta, M., Santos, S., Brazma, A., Marioni, J. C., Aebersold, R., Venkitaraman, A. R., & Wickramasinghe, V. O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.025 · Cited by 190
BCOR Involvement in Cancer
Astolfi, A., Fiore, M., Melchionda, F., Indio, V., Bertuccio, S. N., & Pession, A. (2019) · Epigenomics · doi:10.2217/epi-2018-0195 · Cited by 183
New connections between splicing and human disease
Padgett, R. A. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.01.001 · Cited by 194
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
Porta, M. G. D., Alessandrino, E. P., Bacigalupo, A. P., Lint, M. T. V., Malcovati, L., Pascutto, C., Falda, M., Bernardi, M., Onida, F., Guidi, S., et al. (2014) · Blood · doi:10.1182/blood-2013-12-542720 · Cited by 183
Targeting mRNA processing as an anticancer strategy
Desterro, J. M. P., Bak‐Gordon, P., & Carmo‐Fonseca, M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0042-3 · Cited by 181
Molecular classification and diagnostics of upper urinary tract urothelial carcinoma
Fujii, Y. R., Sato, Y., Suzuki, H., Kakiuchi, N., Yoshizato, T., Lenis, A. T., Maekawa, S., Yokoyama, A., Takeuchi, Y., Inoue, Y., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.008 · Cited by 184
Self-citation
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
Visconte, V., Rogers, H. J., Singh, J., Barnard, J., Bupathi, M., Traina, F., McMahon, J. T., Makishima, H., Szpurka, H., Jankowska, A. M., et al. (2012) · Blood · doi:10.1182/blood-2012-05-430876 · Cited by 182
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies
Kluk, M., Lindsley, R. C., Aster, J. C., Lindeman, N. I., Szeto, D. P., Hall, D., & Kuo, F. C. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.02.003 · Cited by 180
Alternative splicing: decoding an expansive regulatory layer
Irimia, M., & Blencowe, B. J. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.03.005 · Cited by 177
Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability
Savage, K. I., Gorski, J. J., Barros, E. M., Irwin, G. W., Manti, L., Powell, A. J., Pellagatti, A., Lukashchuk, N., McCance, D. J., McCluggage, W. G., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.021 · Cited by 177
Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome
Shao, C., Yang, B., Wu, T., Huang, J. S., Tang, P., Zhou, Y., Zhou, J. J., Qiu, J., Jiang, L., Li, H., et al. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2906 · Cited by 177
Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma
Seki, M., Nishimura, R., Yoshida, K., Shimamura, T., Shiraishi, Y., Sato, Y., Kato, M., Chiba, K., Tanaka, H., Hoshino, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms8557 · Cited by 182
Self-citation
Biological validation that SF3b is a target of the antitumor macrolide pladienolide
Yokoi, A., Kotake, Y., Takahashi, K., Kadowaki, T., Matsumoto, Y., Minoshima, Y., Sugi, N. H., Sagane, K., Hamaguchi, M., Iwata, M., et al. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08387.x · Cited by 176
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
Zhang, L., Tran, N. T., Su, H., Wang, R. Y., Lu, Y., Tang, H., Aoyagi, S., Guo, A., Khodadadi‐Jamayran, A., Zhou, D., et al. (2015) · eLife · doi:10.7554/elife.07938 · Cited by 176
From human genome to cancer genome: The first decadePreprint
Wheeler, D. A., & Wang, L. (2013) · Genome Research · doi:10.1101/gr.157602.113 · Cited by 183
SF3B1 mutations constitute a novel therapeutic target in breast cancer
Maguire, S. L., Leonidou, A., Wai, P. T., Marchiò, C., Ng, C. K. Y., Sapino, A., Vincent‐Salomon, A., Reis-Filho, J. S., Weigelt, B., & Natrajan, R. (2014) · The Journal of Pathology · doi:10.1002/path.4483 · Cited by 178
Genetics of progression from MDS to secondary leukemia
Menssen, A. J., & Walter, M. J. (2020) · Blood · doi:10.1182/blood.2019000942 · Cited by 182

Authors: Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., Chalkidis, G., Suzuki, Y., Shiosaka, M., Kawahata, R., Yamaguchi, T., Otsu, M., Obara, N., Sakata-Yanagimoto, M., Ishiyama, K., Mori, H., Nolte, F., Hofmann, W.-K., Miyawaki, S., Sugano, S., Haferlach, C., Koeffler, H. P., Shih, L.-Y., Haferlach, T., Chiba, S., Nakauchi, H., Miyano, S., & Ogawa, S.
Affiliations: The University of Tokyo (JP)
Institute of Medical Science, The University of Tokyo (JP)
Heidelberg University (DE)
Japan Science and Technology Agency (JP)
University of Tsukuba (JP)
Tokyo Metropolitan Ohtsuka Hospital (JP)
SHOWA Medical University Fujigaoka Hospital (JP)
Munich Leukemia Laboratory (Germany) (DE)
Cedars-Sinai Medical Center (US)
Chang Gung University (TW)
Corresponding author: Ogawa, Seishi
ORCID: Yoshida, Kenichi
Sanada, Masashi
Shiraishi, Yuichi
Nowak, Daniel
Nagata, Yasunobu
Sato, Yusuke
Kon, Ayana
Nagasaki, Masao
Suzuki, Yutaka
Yamaguchi, Tomoyuki
Otsu, Makoto
Obara, Naoshi
Ishiyama, Ken
Nolte, Florian
Miyawaki, Shuichi
Sugano, Sumio
Haferlach, Claudia
Koeffler, H. Phillip
Shih, Lee-Yung
Haferlach, Torsten
Chiba, Shigeru
Nakauchi, Hiromitsu
Miyano, Satoru
Ogawa, Seishi
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2011-09-11
Volume: 478
Issue: 7367
Pages: 64-69
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10496
OpenAlex: W2073889874
Cited by: 2,029
References: 37
Citations by year: 2026: 71 · 2025: 76 · 2024: 121 · 2023: 101 · 2022: 139 · 2021: 160 · 2020: 148 · 2019: 135 · 2018: 135 · 2017: 148 · 2016: 146 · 2015: 145 · 2014: 173 · 2013: 171 · 2012: 135
FWCI: 64.98
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Japan Society for the Promotion of Science (22390191, 23791075, 22790895, 23659533, 23659482, 23390269, 23791068, 22659058)
National Cancer Institute (R01CA026038)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: myelodysplastic syndrome, splicing mutation, U2AF35, ZRSR2, SRSF2, SF3B1, 3' splice site recognition, pre-mRNA splicing, hematopoiesis, acute myeloid leukemia, myeloid neoplasms, aberrant splicing, therapeutic target
MeSH terms: Splicing Factor U2AF, Hematopoiesis, Humans, Mutation, Myelodysplastic Syndromes, Nuclear Proteins, Ribonucleoproteins, RNA Splicing, Spliceosomes, Alternative Splicing, Polymorphism, Single Nucleotide, RNA Splice Sites, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequent pathway mutations of splicing machinery in myelodysplasia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks